Collapse · drug companies withdraw varieties like a flood (Part 4)

It's almost a month since 2015 It seems that pharmaceutical companies haven't made 2016 plans, right? That said, how to do it?! This has been listed varieties, bidding is to haggle over the price, at any time may abandon the bid Abandoned the standard provinces and cities to raise the team for many years, but became a heart disease, leaving is a problem It's a new variety It's all back to stir fried pork I can't find the way behind it Look, it's midnight The drug administration has turned on the searchlight to light up the naked people The way home ~ ~ this time, it's 199 acceptance numbers of 128 enterprises to follow the army and perform Dunkirk retreat! Here, we need to correct our understanding After grandpa Bi's speech last week, many people said that the drug administration shot 80% of the self-examination varieties Don't get me wrong Withdrawing doesn't mean shooting Withdraw the variety, make up some materials, wash it white, and report it back! So far, only 34 acceptance numbers have been shot in the self-examination Get back to the point Just like the previous trilogy, let's take stock of the latest progress, and then gradually discuss the strange ideas and topics The bottom of the box should always be put behind I the latest self inspection results last week, at the national food and drug supervision and administration and party conduct and clean government construction conference held in Beijing, Grandpa Bi mentioned that there were 1151 withdrawals and disapprovals (as of January 12, 2016) Just a week later, as of today, the number of withdrawals plus disapprovals has risen to 1184 Based on the original 1622 acceptance numbers, 73% of them were withdrawn and disapproved If 165 clinical acceptance numbers are deducted, the proportion of withdrawal plus disapproval has reached 81% Note: we have noticed that the number of exemption clinical acceptance numbers has decreased from 193 to 165, that is, 28 exemption clinical acceptance numbers have also been withdrawn All the following statistics are not included in the 165 acceptance numbers of clinical exemption 2 The situation of provinces and cities is shown in the figure below This result is really cruel At present, 10 provinces and cities, including Anhui, Guizhou, Jiangxi, Inner Mongolia, Ningxia, Qinghai, Shanxi, Shaanxi, Tianjin and Xinjiang, have withdrawn their baldness The fiercest is Shandong Of the 125 acceptance numbers, only one survived It turns out to be Qilu's Tenofovir disoproxil fumarate tablets This is interesting This variety is valuable! Turning around and looking at foreigners, only 31 of 151 self-examination acceptance numbers were withdrawn, with a survival rate of 79%, which is really strong We have combined all the acceptance numbers of domestic enterprises, 1291 in total, 153 of which are still alive, with a survival rate of 11.9% Both domestic and foreign enterprises are in hot water Let's see what the accounts of the production enterprises look like First of all, the same acceptance number may be jointly declared by multiple enterprises We split it and count it independently Unless otherwise, the company's synonyms have been modified (some new ones have been found) You can rest assured that no enterprise will escape from the magic of statistics It is still according to the statistical method of the third part, as shown in the figure below At present, there are still 126 enterprises whose acceptance numbers remain unchanged and insist on not withdrawing, only 17.8% of them On the contrary, 77% of the enterprises (545 enterprises) have withdrawn the acceptance number and are basically weaned, that is to say, there will be no new products going on the market in the next three years And so on Survival rate: number of enterprises: 0%, 545, 77.1%, 6%
1
0.1%
14%
1
0.1%
17%
3
0.4%
20%
2
0.3%
22%
1
0.1%
24%
1
0.1%
25%
2
0.3%
33%
4
0.6%
40%
1
0.1%
50%
12
1.7%
56%
1
0.1%
60%
1
0.1%
67%
3
0.4%
71%
2
0.3%
80%
1
0.1% 100% 126 17.8% now is a tense time Let's take a look at the list of specific enterprises In order to ease the mood, the music starts If it wasn't for your longing for eyes, if it wasn't for my redeeming mood, we would meet in a sea of mountains and rivers Oh, so you are here The things that should be concealed are always clear Thousands of words can only be silent Love is a superstition of time and place Oh, so you are here First bitter and then sweet, let's see which enterprises have all been eliminated (too many, only those with more acceptance numbers are listed) After three minutes, how can I catch up? From the beginning to the end, I see all the shining star enterprises To say that these years, enterprises have really suffered a lot of losses, so they have developed a lot of good habits As soon as the state has established the catalogue, no matter what the catalogue, the first reaction must be advanced, otherwise it will be a big loss; of course, except for the catalogue of auxiliary drugs started last year As soon as I heard that there were rankings, especially those of the Ministry of industry and information technology, the response of enterprises was to be ahead of the others It can only be said that the self-examination of this list may also be affected by this mentality, and it is so popular Small reminder: the list is long, click the picture to see the original picture more clearly! Take a look at the sweet list Take a look at which enterprises are the most powerful, and insist that Qingshan will not relax, and that they will not withdraw even if they are killed! 4 The clinical study of cro is really a mixture of anesthesia When an acceptance number is withdrawn, it may be the responsibility of the cro or the base What's more, the clinical trials of a drug are unlikely to be undertaken by a base Everyone is on the same rope, once there is a problem in a certain link, they will be affected We also note that what the National Bureau has announced is only the leading clinical base Alas, there are risks in taking the lead Whether it's your own problems or the work of participating units, it's up to you in the end Somehow, I always want to read this tongue twister Put a basin on the table There's a bottle in the basin It's popping I don't know whether it's the bottle touching the basin or the basin touching the bottle Because of the limited space, the statistics of clinical base will not be released There is something more important!! V is the acceptance number out of the sight of the masses? Senior Chaoyang District people will think, will some acceptance number has been finalized, but did not appear in the above list? OK, there is a database of drug registration progress in medicine magic cube, please pull it right away Ha ha ha, some of the acceptance numbers in the self-examination list were shot by or withdrawn from CDE, and did not go to the clinical verification center Most foreigners! 6 It's hard luck, but it's self-examination after review When it comes to self-examination, everyone is depressed In fact, there are more depressed Some acceptance numbers, which have already passed the technical review, are about to be issued At this time, self inspection is coming! Subsequently, some varieties were withdrawn in the self-examination! Of course, the excellent varieties are relatively depressed They should have been approved for a long time, and they should rush to participate in the provincial bidding Come to self-examination, the big target of once in five years will be empty Alas, helpless Seven, lucky egg, just avoid self-examination The clinical trial self-examination started on July 22 Just before the self-examination, a batch of varieties were approved for production Fortunately, they escaped the self-examination Of course, the luckiest thing is not self-examination, but to be able to participate in provincial bidding calmly The rhythm is just right We came here with envious eyes and drool Leave some good mood for the new year, this article will be the luckiest acceptance number up to now Never break, never stand, Nirvana reborn After the storm, the pattern of drug research and development has changed greatly If we master the data and make progress, there will be the rise of pharmaceutical companies in the new era Let's wait and see! By the way, in the near future, we will integrate the five factors of clinical self-examination, consistency evaluation, GMP production suspension, zombie number and non production varieties to comb out the real domestic drug number resources in China, which is unprecedented Hey hey, you know, these five factors will completely affect the number of listed and R & D competition of a variety, from which we can tap the potential gold varieties in the future Those who are interested and have resources can communicate with us!